Scientists discuss and explain the most recent advances in chimeric antigen receptor (CAR) T cell-based therapies targeting acute myeloid leukemia (AML) antigens and review the results of preclinical and clinical trials.
[Stem Cell Research & Therapy]
7992332
{7992332:MMMKRHWQ}
apa
50
1
165991
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
